| ELTX Stock | | | 4.59 0.33 7.75% |
Elicio Therapeutics financial indicator trend analysis is much more than just examining Elicio Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Elicio Therapeutics is a good investment. Please check the relationship between Elicio Therapeutics Non Currrent Assets Other and its Accounts Payable accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elicio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Elicio Stock please use our
How to Invest in Elicio Therapeutics guide.
Non Currrent Assets Other vs Accounts Payable
Non Currrent Assets Other vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Elicio Therapeutics Non Currrent Assets Other account and
Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Elicio Therapeutics' Non Currrent Assets Other and Accounts Payable is 0.88. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Elicio Therapeutics, assuming nothing else is changed. The correlation between historical values of Elicio Therapeutics' Non Currrent Assets Other and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Elicio Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Non Currrent Assets Other i.e., Elicio Therapeutics' Non Currrent Assets Other and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.88 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Accounts Payable
An accounting item on the balance sheet that represents Elicio Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Elicio Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Elicio Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Elicio Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elicio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Elicio Stock please use our
How to Invest in Elicio Therapeutics guide.
Issuance Of Capital Stock is likely to rise to about 10.3
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 6.8
M in 2024.
Elicio Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Elicio Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Elicio Stock Analysis
When running Elicio Therapeutics' price analysis, check to
measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.